Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) = Immunotherapy
  • (-) ≠ Kapiteijn, E.
  • (-) = Fathers, L.M.

Search results

  • RSS Feed
(1 - 4 of 4)
The long-term immune response after HPV16 peptide vaccination in women with low-grade pre-malignant disorders of the uterine cervix: a placebo-controlled phase II study
Steenwijk, P.J.D. van; Poelgeest, M.I.E. van; Ramwadhdoebe, T.H.; Lowik, M.J.G.; Berends-van der Meer, D.M.A.; Minne, C.E. van der; ... ; Kenter, G.G. 2014
The long-term immune response after HPV16 peptide vaccination in women with low-grade pre-malignant disorders of the uterine cervix: a placebo-controlled phase II study
Article / Letter to editor
metadata only
HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial
Poelgeest, M.I.E. van; Welters, M.J.P.; Esch, E.M.G. van; Stynenbosch, L.F.M.; Kerpershoek, G.; Meerten, E.L.V. van; ... ; Burg, S.H. van der 2013
HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial
Article / Letter to editor
metadata only
HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial
Poelgeest, M.I.E. van; Welters, M.J.P.; Esch, E.M.G. van; Stynenbosch, L.F.M.; Kerpershoek, G.; Meerten, E.L.V. van; ... ; Burg, S.H. van der 2013
HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial
Article / Letter to editor
metadata only
A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions
Steenwijk, P.J.D. van; Ramwadhdoebe, T.H.; Lowik, M.J.G.; Minne, C.E. van der; Berends-van der Meer, D.M.A.; Fathers, L.M.; ... ; Burg, S.H. van der 2012
A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions
Article / Letter to editor
metadata only